Literature DB >> 18632624

Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.

Jung-Hye Choi1, Joon T Park, Ben Davidson, Patrice J Morin, Ie-Ming Shih, Tian-Li Wang.   

Abstract

Notch3 gene amplification and pathway activation have been reported in ovarian serous carcinoma. However, the primary Notch3 ligand that initiates signal transduction in ovarian cancer remains unclear. In this report, we identify Jagged-1 as the highest expressed Notch ligand in ovarian tumor cells as well as in peritoneal mesothelial cells that are in direct contact with disseminated ovarian cancer cells. Cell-cell adhesion and cellular proliferation were reduced in Notch3-expressing ovarian cancer cells that were cocultured with Jagged-1 knockdown mesothelial and tumor feeder cells. Interaction of Notch3-expressing ovarian cancer cells with Jagged-1-expressing feeder cells activated the promoter activity of candidate Notch3 target genes, and this activity was attenuated by Notch3 siRNA. Constitutive expression of the Notch3 intracellular domain significantly suppressed the Jagged-1 shRNA-mediated growth inhibitory effect. In Notch3-expressing ovarian cancer cells, Jagged-1-stimulating peptides enhanced cellular proliferation, which was suppressed by gamma-secretase inhibitor and Notch3 siRNA. Taken together, our results show that Jagged-1 is the primary Notch3 ligand in ovarian carcinoma and Jagged-1/Notch3 interaction constitutes a juxtacrine loop promoting proliferation and dissemination of ovarian cancer cells within the intraperitoneal cavity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632624      PMCID: PMC2562671          DOI: 10.1158/0008-5472.CAN-08-0001

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.

Authors:  T Ohtsuka; M Ishibashi; G Gradwohl; S Nakanishi; F Guillemot; R Kageyama
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 2.  Notch signaling, gamma-secretase inhibitors, and cancer therapy.

Authors:  Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

3.  Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.

Authors:  Kentaro Nakayama; Naomi Nakayama; Robert J Kurman; Leslie Cope; Gudrun Pohl; Yardena Samuels; Victor E Velculescu; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Biol Ther       Date:  2006-07-26       Impact factor: 4.742

4.  Notch3 gene amplification in ovarian cancer.

Authors:  Joon T Park; Mei Li; Kentaro Nakayama; Tsui-Lien Mao; Ben Davidson; Zhen Zhang; Robert J Kurman; Charles G Eberhart; Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Notch3 signaling promotes radial glial/progenitor character in the mammalian telencephalon.

Authors:  Louis Dang; Keejung Yoon; Mike Wang; Nicholas Gaiano
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

6.  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.

Authors:  Benjamin W Purow; Raqeeb M Haque; Martha W Noel; Qin Su; Michael J Burdick; Jeongwu Lee; Tilak Sundaresan; Sandra Pastorino; John K Park; Irina Mikolaenko; Dragan Maric; Charles G Eberhart; Howard A Fine
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  Amplicon profiles in ovarian serous carcinomas.

Authors:  Kentaro Nakayama; Naomi Nakayama; Natini Jinawath; Ritu Salani; Robert J Kurman; Ie-Ming Shih; Tian-Li Wang
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

Review 8.  Mechanisms of transcoelomic metastasis in ovarian cancer.

Authors:  David S P Tan; Roshan Agarwal; Stanley B Kaye
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

Review 9.  Multiple niches for Notch in cancer: context is everything.

Authors:  Andrew P Weng; Jon C Aster
Journal:  Curr Opin Genet Dev       Date:  2004-02       Impact factor: 5.578

10.  Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Authors:  M F Kohler; J R Marks; R W Wiseman; I J Jacobs; A M Davidoff; D L Clarke-Pearson; J T Soper; R C Bast; A Berchuck
Journal:  J Natl Cancer Inst       Date:  1993-09-15       Impact factor: 13.506

View more
  56 in total

1.  Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Blake Goodman; Hee-Dong Han; Alpa M Nick; Rebecca L Stone; Robert L Coleman; Ronald D Alvarez; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen
Journal:  Clin Cancer Res       Date:  2011-07-13       Impact factor: 12.531

2.  Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.

Authors:  Chao-Cheng Huang; Shih-Hsuan Cheng; Chen-Hsuan Wu; Wen-Yuan Li; Jiang-Shiang Wang; Mei-Lang Kung; Tian-Huei Chu; Shih-Tsung Huang; Chien-Ting Feng; Shih-Chung Huang; Ming-Hong Tai
Journal:  Oncogene       Date:  2019-01-09       Impact factor: 9.867

Review 3.  The Role of Notch3 in Cancer.

Authors:  Zviadi Aburjania; Samuel Jang; Jason Whitt; Renata Jaskula-Stzul; Herbert Chen; J Bart Rose
Journal:  Oncologist       Date:  2018-04-05

4.  Identification of the NAC1-regulated genes in ovarian cancer.

Authors:  Min Gao; Ren-Chin Wu; Alice L Herlinger; Kailee Yap; Jung-Won Kim; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

5.  Activation dynamics and signaling properties of Notch3 receptor in the developing pulmonary artery.

Authors:  Shamik Ghosh; Jesus R Paez-Cortez; Karthik Boppidi; Michelle Vasconcelos; Monideepa Roy; Wellington Cardoso; Xingbin Ai; Alan Fine
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

6.  Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.

Authors:  Dongjun Peng; Takashi Tanikawa; Wei Li; Lili Zhao; Linda Vatan; Wojciech Szeliga; Shanshan Wan; Shuang Wei; Yin Wang; Yan Liu; Elzbieta Staroslawska; Franciszek Szubstarski; Jacek Rolinski; Ewelina Grywalska; Andrzej Stanisławek; Wojciech Polkowski; Andrzej Kurylcio; Celina Kleer; Alfred E Chang; Max Wicha; Michael Sabel; Weiping Zou; Ilona Kryczek
Journal:  Cancer Res       Date:  2016-04-06       Impact factor: 12.701

7.  Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.

Authors:  Fengxin Zhu; Tang Li; Fanghua Qiu; Jinjin Fan; Qin Zhou; Xuebing Ding; Jing Nie; Xueqing Yu
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

8.  Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer.

Authors:  Xu Chen; Alexander Stoeck; Soo Jung Lee; Ie-Ming Shih; Michael M Wang; Tian-Li Wang
Journal:  Oncotarget       Date:  2010-07

9.  The role of Notch and gamma-secretase inhibition in an ovarian cancer model.

Authors:  Monjri M Shah; Marielba Zerlin; Blake Y Li; Thomas J Herzog; Jan K Kitajewski; Jason D Wright
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

10.  Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.

Authors:  Nathan J Bowen; L DeEtte Walker; Lilya V Matyunina; Sanjay Logani; Kimberly A Totten; Benedict B Benigno; John F McDonald
Journal:  BMC Med Genomics       Date:  2009-12-29       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.